Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Locally Advanced Breast Cancer and Large Operable Breast Cancer”

8 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 8 of 8 results

Large-scale testing (Phase 3)Ended earlyNCT01608451
What this trial is testing

Randomized Controlled Trial of Neo-adjuvant Progesterone and Vitamin D3 in Women With Large Operable Breast Cancer and Locally Advanced Breast Cancer

Who this might be right for
Locally Advanced Breast Cancer and Large Operable Breast Cancer
Tata Memorial Hospital 800
Large-scale testing (Phase 3)Study completedNCT00017095
What this trial is testing

Biomarker (p53 Gene) Analysis and Combination Chemotherapy Followed by Radiation Therapy and Surgery in Treating Women With Large Operable or Locally Advanced or Inflammatory Breast Cancer

Who this might be right for
Breast Cancer
European Organisation for Research and Treatment of Cancer - EORTC 1,856
Large-scale testing (Phase 3)Study completedNCT00232661
What this trial is testing

PROACT - Pre-Operative Arimidex Compared To Tamoxifen

Who this might be right for
Breast Cancer
AstraZeneca 452
Testing effectiveness (Phase 2)Study completedNCT00191789
What this trial is testing

Neoadjuvant Sequential Administration of Two Gemcitabine Combinations in Operable Breast Cancer

Who this might be right for
Breast Cancer
Eli Lilly and Company 65
Large-scale testing (Phase 3)Active Not RecruitingNCT03168880
What this trial is testing

Controlled Trial of Neoadjuvant Weekly Paclitaxel Versus Weekly Paclitaxel Plus Weekly Carboplatin In Women With Large Operable or Locally Advanced, Triple Negative Breast Cancer

Who this might be right for
Triple Negative Breast Cancer
Tata Memorial Hospital 720
Testing effectiveness (Phase 2)Study completedNCT00450892
What this trial is testing

Phase I/II Study of Neoadjuvant Lapatinib in Breast Cancer

Who this might be right for
Breast Cancer
European Organisation for Research and Treatment of Cancer - EORTC 129
Large-scale testing (Phase 3)Study completedNCT02003209
What this trial is testing

Docetaxel, Carboplatin, Trastuzumab, and Pertuzumab With or Without Estrogen Deprivation in Treating Patients With Hormone Receptor-Positive, HER2-Positive Operable or Locally Advanced Breast Cancer

Who this might be right for
HER2-Positive Breast CarcinomaHormone Receptor-Positive Breast CarcinomaStage IB Breast Cancer AJCC v7+5 more
National Cancer Institute (NCI) 315
Early research (Phase 1)Study completedNCT00008034
What this trial is testing

Combination Chemotherapy Before Surgery in Treating Women With Breast Cancer

Who this might be right for
Breast Cancer
European Organisation for Research and Treatment of Cancer - EORTC 15